Search research articles
Contact Us
Filters
Showing results (131-140 of 153) with videos related to
Page
of 16
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 5, 2008
A role for ceramide in driving cancer cell resistance to doxorubicin
Yong-Yu Liu, Jing Yuan Yu, Dongmei Yin, et al.
Molecular Cancer Therapeutics
|
September 16, 2008
N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing
Hongtao Wang, Barry J Maurer, Yong-Yu Liu, et al.
Molecular Cancer Research : MCR
|
November 21, 2019
Ceramide Analogue SACLAC Modulates Sphingolipid Levels and <i>MCL-1</i> Splicing to Induce Apoptosis in Acute Myeloid Leukemia
Jennifer M Pearson, Su-Fern Tan, Arati Sharma, et al.
Journal of Leukemia (Los Angeles, Calif.)
|
February 28, 2017
Engraftment of Human Primary Acute Myeloid Leukemia Defined by Integrated Genetic Profiling in NOD/SCID/IL2rγnull Mice for Preclinical Ceramide-Based Therapeutic Evaluation
Brian M Barth, Nichole R Keasey, Xujung Wang, et al.
Biochimica Et Biophysica Acta. Bioenergetics
|
September 4, 2022
Intrinsic adaptations in OXPHOS power output and reduced tumorigenicity characterize doxorubicin resistant ovarian cancer cells
James T Hagen, McLane M Montgomery, Ericka M Biagioni, et al.
Elife
|
June 16, 2021
Intrinsic OXPHOS limitations underlie cellular bioenergetics in leukemia
Margaret Am Nelson, Kelsey L McLaughlin, James T Hagen, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid Leukemia
Johnson Ung, Su-Fern Tan, Todd E Fox, et al.
Cancer Biology & Therapy
|
July 29, 2011
Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer
Yixing Jiang, Nicole A DiVittore, James M Kaiser, et al.
Journal of Lipid Research
|
April 10, 2019
Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-κB-dependent P-glycoprotein upregulation
Su-Fern Tan, Wendy Dunton, Xin Liu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 10, 2021
Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia
Kelsey H Fisher-Wellman, James T Hagen, Miki Kassai, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 153) with videos related to
Sort By:
Page
of 16
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 5, 2008
A role for ceramide in driving cancer cell resistance to doxorubicin
Yong-Yu Liu, Jing Yuan Yu, Dongmei Yin, et al.
Molecular Cancer Therapeutics
|
September 16, 2008
N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing
Hongtao Wang, Barry J Maurer, Yong-Yu Liu, et al.
Molecular Cancer Research : MCR
|
November 21, 2019
Ceramide Analogue SACLAC Modulates Sphingolipid Levels and <i>MCL-1</i> Splicing to Induce Apoptosis in Acute Myeloid Leukemia
Jennifer M Pearson, Su-Fern Tan, Arati Sharma, et al.
Journal of Leukemia (Los Angeles, Calif.)
|
February 28, 2017
Engraftment of Human Primary Acute Myeloid Leukemia Defined by Integrated Genetic Profiling in NOD/SCID/IL2rγnull Mice for Preclinical Ceramide-Based Therapeutic Evaluation
Brian M Barth, Nichole R Keasey, Xujung Wang, et al.
Biochimica Et Biophysica Acta. Bioenergetics
|
September 4, 2022
Intrinsic adaptations in OXPHOS power output and reduced tumorigenicity characterize doxorubicin resistant ovarian cancer cells
James T Hagen, McLane M Montgomery, Ericka M Biagioni, et al.
Elife
|
June 16, 2021
Intrinsic OXPHOS limitations underlie cellular bioenergetics in leukemia
Margaret Am Nelson, Kelsey L McLaughlin, James T Hagen, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid Leukemia
Johnson Ung, Su-Fern Tan, Todd E Fox, et al.
Cancer Biology & Therapy
|
July 29, 2011
Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer
Yixing Jiang, Nicole A DiVittore, James M Kaiser, et al.
Journal of Lipid Research
|
April 10, 2019
Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-κB-dependent P-glycoprotein upregulation
Su-Fern Tan, Wendy Dunton, Xin Liu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 10, 2021
Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia
Kelsey H Fisher-Wellman, James T Hagen, Miki Kassai, et al.
Page
of 16